Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06948838 · ClinicalTrials.gov registry record · NA

Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment

A NA study of Hypertension and Hypertension Complicated, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
16,895
Enrollment target
7
Study locations

NCT06948838: Recruiting NA study of Hypertension and Hypertension Complicated, sponsored by Boston Medical Center.

NCT06948838 is a NA study of Hypertension and Hypertension Complicated that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 16,895 participants, above the 3,471-participant average among 470 other Hypertension trials with a reported enrollment target (387% higher). The trial reports 7 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06948838, a NA study of Hypertension and Hypertension Complicated, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
16,895 participants
Enrollment target
7
Study locations

Study Summary

High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication classes. Successful HTN management requires ongoing patient engagement for BP monitoring and treatment intensification. Reaching this goal is challenging, and many patients with HTN do not have controlled BP. Using a collaborative partnership between patients, clinicians, health system and public health stakeholders, and the research team the investigators plan to overcome barriers to widespread implementation of evidence-based health system strategies to improve BP control in a large, urban, primary care-based safety-net setting for diverse populations experiencing disparities in HTN-related outcomes.

Primary Outcome

Change in BP abstracted from the electronic health record (EHR).

Interventions

  • BEHAVIORAL RBPM
  • OTHER MII

Study Locations (7)

Massachusetts

  • Boston Healthcare for the Homeless (BHCHP) - Boston
  • Boston Medical Center Family Medicine - Boston
  • Boston Medical Center, General Internal Medicine primary care - Boston
  • Neighborhood Health - Boston
  • Mattapan Community Health Center - Boston
  • Manet Community Health Center - Quincy
  • Greater Roslindale Medical and Dental Center (GRMDC) - Roslindale

Trial Details

FieldValue
Enrollment Target 16,895 participants
Start Date 2025-09-08
Est. Completion 2029-09
Phase NA
Boston Medical Center

253 total trials

What NCT06948838 shows while recruiting

NCT06948838 is an interventional study that assigns participants to a tested intervention. Its 16,895 participants enrollment target places it among the larger protocols in the corpus, above the 3,471-participant average among 470 other Hypertension trials with a reported enrollment target (387% higher).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which RBPM is the first listed.

NCT06948838 lists 7 locations in 1 state (Massachusetts).

Frequently Asked Questions

What is clinical trial NCT06948838 about?

NCT06948838 is a clinical study titled "Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment". High blood pressure (BP) or hypertension (HTN) affects over 100 million individuals in the US, increasing the risk of adverse outcomes, including stroke, myocardial infarction (MI), and chronic kidney disease (CKD). Effective therapies include non-pharmacologic approaches and multiple medication cla...

What is the current status of trial NCT06948838?

This trial is currently recruiting. It is a NA study. The enrollment target is 16,895 participants. The study started on 2025-09-08. Estimated completion is 2029-09.

What conditions does trial NCT06948838 study?

This clinical trial studies the following conditions: Hypertension, Hypertension Complicated.

What interventions are being tested in trial NCT06948838?

The interventions under investigation include: RBPM (BEHAVIORAL), MII (OTHER).

Who is sponsoring clinical trial NCT06948838?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06948838 being conducted?

This trial has 7 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06948838's enrollment target sits among peer trials

16,895 15th of 470 higher than 456 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06479447 · 17,000 participants · NA

    Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder

  • NCT06951867 · 16,640 participants

    Tezspire Cardiac Events PASS

  • NCT06245187 · 17,198 participants

    Get With the Guidelines Atrial Fibrillation Registry

  • NCT06272110 · 17,500 participants

    Promoting Equitable Access to Language Services in Health and Human Services

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06948838, the US trial registry maintained by the National Library of Medicine. NCT06948838 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.